LBT Innovations in first US sale of pharma lab system

Automated laboratory systems manufacturer LBT Innovations has completed the sale of an APAS Independence instrument (pictured) to Bristol Myers Squibb in the United States, the first to a pharmaceutical customer in the US. The APAS Independence instrument utilises artificial intelligence, image analysis and software engineering to monitor quality in a pharmaceutical manufacturing facility by automating…

LBT Innovations sells five pharma QC systems

Microbiology automation company LBT Innovations has sold five APAS Independence laboratory instruments to pharmaceutical manufacturer AstraZeneca AB and will provide maintenance and support services over seven years. The total contract value is worth up to $4.1 million depending on the level of services required, and is in addition to the lease of a sixth instrument…

LBT Innovations PharmaQC device ‘commercially ready’

Laboratory automation manufacturer LBT Innovations has announced that its APAS PharmaQC automated pharmaceutical manufacturing quality control system was now commercially ready after an extensive period of R&D. Primary validation of the device has been completed and the technology formally released to pharmaceutical manufacturer AstraZeneca, a partner in the development. APAS PharmaQC provides automated imaging, analysis…